Estadístiques de Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry
Visites totals
| views | |
|---|---|
| Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry | 2 |
Visites totals per mes
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 2 |
| December 2024 | 0 |
| January 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Obach_jhp_long.pdf(legacy) | 3 |
| Obach_jhp_long.pdf | 1 |
Vistes principals per país
| views | |
|---|---|
| Mongolia | 1 |
| United States | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Sacramento | 1 |
| Ulaanbaatar | 1 |